首页 >
法规速递
-
Page: Healthcare professionals: Key documents-2025/7/2
2025-07-03查看详情 > -
Document: Declaration of interest form: Public call for Scientific Advisory Group on Immune and Inflammatory Diseases-2025/8/5
2025-08-06查看详情 > -
Document: Mandate and objectives for the Working Group of the MSSG on the Voluntary Solidarity Mechanism and Policy-2025/9/24
2025-09-25查看详情 > -
关于公开征求ICH《Q8、Q9和Q10问答（R5）》实施建议意见的通知-2025/10/31
2025-11-03查看详情 > -
Page: Stakeholders and Communication-2025/12/1
2025-12-02查看详情 > -
国家药监局关于调整《医疗器械分类目录》部分内容的公告（2025年第132号）-2026/1/4
2026-01-05查看详情 > -
国家药监局关于参倍固肠胶囊和儿童清咽解热口服液转换为非处方药的公告（2026年第19号）-2026/2/10
2026-02-10查看详情 > -
Document: Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (X-39)-2026/3/17
2026-03-18查看详情 > -
Document: Annex to agenda of the CHMP meeting 20-23 April 2026-2026/4/20
2026-04-21查看详情 > -
国家药监局药审中心关于发布《放射性体内治疗药物临床评价技术指导原则》的通告（2023年第9号）-2023/02/15
2023-02-15查看详情 >
